Pro Medicus Limited
PME
Classifica tra le azioni
#1597
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Prezzo delle azioni
$129.30
Capitalizzazione di mercato
$13.51B
Variazione (1 giorno)
-0.17%
Variazione (1 anno)
-30.83%
Paese
AU
Scambia Pro Medicus Limited (PME)
Categoria
Healthcare
Ricavi di Pro Medicus Limited (PME)
Ricavi nel Jun 2026 TTM: $184.56M
Secondo gli ultimi rapporti finanziari di Pro Medicus Limited, i ricavi attuali dell'azienda (TTM) sono pari a $184.56M. Nel 2024, l'azienda ha registrato ricavi di $107.79M un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $83.22M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Pro Medicus Limited da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $184.56M | 31.68% |
| 2025 | $140.16M | 30.03% |
| 2024 | $107.79M | 29.52% |
| 2023 | $83.22M | 29.09% |
| 2022 | $64.46M | 26.65% |
| 2021 | $50.90M | 29.82% |
| 2020 | $39.21M | 11.42% |
| 2019 | $35.19M | 32.27% |
| 2018 | $26.60M | 9.34% |
| 2017 | $24.33M | 18.68% |
| 2016 | $20.50M | 52.25% |
| 2015 | $13.47M | 0.06% |
| 2014 | $13.46M | 32.04% |
| 2013 | $10.19M | -11.85% |
| 2012 | $11.56M | -22.81% |
| 2011 | $14.98M | -7.87% |
| 2010 | $16.26M | 102.15% |
| 2009 | $8.04M | -8.44% |
| 2008 | $8.78M | -17.50% |
| 2007 | $10.65M | 26.89% |
| 2006 | $8.39M | 7.33% |
| 2005 | $7.82M | 42.49% |
| 2004 | $5.49M | -10.08% |
| 2003 | $6.10M | 6.64% |
| 2002 | $5.72M | 12.69% |
| 2001 | $5.08M | 0.00% |
| 2000 | 0.00 | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $20.24B | 10,867.98% |
US
|
|
| $14.37B | 7,686.76% |
US
|
|
| $1.43B | 675.89% |
US
|
|
| $616.91M | 234.25% |
US
|
|
| - | - |
US
|
